Literature DB >> 1972245

Dose of bisphosphonate for hypercalcaemia of malignancy.

A R Morton, J Friefeld, F Halperin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 1972245     DOI： 10.1016/0140-6736(90)91503-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

1.  A combination of calcitonin and bisphosphonate for the emergency treatment of severe tumor-induced hypercalcemia.

Authors:  K Luce; D E O'Donnell; A R Morton
Journal:  Calcif Tissue Int       Date:  1993-01       Impact factor: 4.333

Review 2.  Drugs used in the treatment of metabolic bone disease. Clinical pharmacology and therapeutic use.

Authors:  S Patel; A R Lyons; D J Hosking
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

3.  Factors predicting the acute effect of pamidronate on serum calcium in hypercalcemia of malignancy.

Authors:  S J Gallacher; W D Fraser; F C Logue; F J Dryburgh; R A Cowan; I T Boyle; S H Ralston
Journal:  Calcif Tissue Int       Date:  1992-12       Impact factor: 4.333
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.